Peter Klinke

The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events

F Mindlen, Roberto Nordaby, M I Soto Ruiz et al. · Queensland's institutional digital repository (The University of Queensland) · 1996 · 154 citations

Medicine, Cardiology, Pharmacotherapy +17

Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome

Gorav Batra, Tatevik Ghukasyan Lakic, Johan Lindbäck et al. · JAMA Cardiology · 2021 · 111 citations · Full text

Medicine, Cardiology, Immunology +15

Vascular Communications of the Hand in Patients Being Considered for Transradial Coronary Angiography

Michael J. Greenwood, Anthony J. Della-Siega, Eric Fretz et al. · Journal of the American College of Cardiology · 2005 · 87 citations

Medicine, Cardiology, Radiology +14

Systemic Nanoparticle Paclitaxel (<i>nab</i>‐Paclitaxel) for In‐stent Restenosis I (SNAPIST‐I): A First‐in‐Human Safety and Dose‐finding Study

James R. Margolis, John W. McDonald, Richard R. Heuser et al. · Clinical Cardiology · 2007 · 84 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Day procedure intervention is safe and complication free in higher risk patients undergoing transradial angioplasty and stenting. The discharge study

Andrew Small, Peter Klinke, Anthony Della Siega et al. · Catheterization and Cardiovascular Interventions · 2007 · 76 citations

Medicine, Cardiology, Surgery +13